Mylan Pharmaceuticals Inc. Recall: Triamterene and Hydrochlorothiazide Tablets, USP 37.5 m
Mylan Pharmaceuticals Inc. Recall: Triamterene and Hydrochlorothiazide Tablets, USP 37.5 m is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Mylan Pharmaceuticals Inc.; Product: Triamterene and Hydrochlorothiazide Tablets, USP 37.5 mg/25 mg, 100-count bottle, Rx only, Mylan Pharmaceutica
| Recalling firm | Mylan Pharmaceuticals Inc. |
|---|---|
| Product | Triamterene and Hydrochlorothiazide Tablets, USP 37.5 mg/25 mg, 100-count bottle, Rx only, Mylan Pharmaceuticals, Inc. Morgantown, WV 26505, NDC 0378-1352-01 |
| Reason for recall | Subpotent Drug |
| Classification | Class III (least serious — unlikely to cause adverse health consequences) |
| Status | Terminated |
| Distribution | Nationwide within the United States |
| Recall initiated | 20180709 |
| Recall number | D-0978-2018 |
| Category | drug |
| State | WV |
| Country | United States |
$29/mo
Try RecallGuard →